Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis.

Kim DH, Beckett JD, Nagpal V, Seman-Senderos MA, Gould RA, Creamer TJ, MacFarlane EG, Chen Y, Bedja D, Butcher JT, Mitzner W, Rouf R, Hata S, Warren DS, Dietz HC.

Sci Transl Med. 2019 Jul 17;11(501). pii: eaau2814. doi: 10.1126/scitranslmed.aau2814.

PMID:
31316008
2.

Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.

Bynum JP, Zachary A, Ness PM, Luo X, Bagnasco S, King KE, Segev DL, Orandi BJ, Warren DS, Fuller A, Ciappi A, Montgomery R, Tobian AAR.

Transfusion. 2018 Aug;58(8):1951-1957. doi: 10.1111/trf.14800. Epub 2018 Sep 1.

3.

A Lean Six Sigma Quality Improvement Project Improves Timeliness of Discharge from the Hospital.

Molla M, Warren DS, Stewart SL, Stocking J, Johl H, Sinigayan V.

Jt Comm J Qual Patient Saf. 2018 Jul;44(7):401-412. doi: 10.1016/j.jcjq.2018.02.006. Epub 2018 May 28.

PMID:
30008352
4.

Laparoscopic Total Pancreatectomy With Islet Autotransplantation and Intraoperative Islet Separation as a Treatment for Patients With Chronic Pancreatitis.

Fan CJ, Hirose K, Walsh CM, Quartuccio M, Desai NM, Singh VK, Kalyani RR, Warren DS, Sun Z, Hanna MN, Makary MA.

JAMA Surg. 2017 Jun 1;152(6):550-556. doi: 10.1001/jamasurg.2016.5707.

5.

Review of predialysis education programs: a need for standardization.

Van den Bosch J, Warren DS, Rutherford PA.

Patient Prefer Adherence. 2015 Sep 9;9:1279-91. doi: 10.2147/PPA.S81284. eCollection 2015. Review.

6.

Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.

Knabel MK, Ramachandran K, Karhadkar S, Hwang HW, Creamer TJ, Chivukula RR, Sheikh F, Clark KR, Torbenson M, Montgomery RA, Cameron AM, Mendell JT, Warren DS.

PLoS One. 2015 Apr 29;10(4):e0124411. doi: 10.1371/journal.pone.0124411. eCollection 2015.

7.

Successful transplantation of kidney allografts in sensitized rats after syngeneic hematopoietic stem cell transplantation and fludarabine.

Fu Y, Sun Z, Fuchs EJ, Wang Y, Shen ZY, Maeda H, Lin Q, Warren DS, Williams GM, Montgomery RA.

Am J Transplant. 2014 Oct;14(10):2375-83. doi: 10.1111/ajt.12815. Epub 2014 Aug 19.

8.

HLA incompatible renal transplantation.

Montgomery RA, Warren DS, Segev DL, Zachary AA.

Curr Opin Organ Transplant. 2012 Aug;17(4):386-92. doi: 10.1097/MOT.0b013e328356132b. Review.

PMID:
22790073
9.

In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.

Lonze BE, Holzer HT, Knabel MK, Locke JE, DiCamillo GA, Karhadkar SS, Montgomery RA, Sun Z, Warren DS, Cameron AM.

Arch Surg. 2012 Apr;147(4):384-7. doi: 10.1001/archsurg.2011.1250.

PMID:
22508787
10.

Outcomes of ABO-incompatible kidney transplantation in the United States.

Montgomery JR, Berger JC, Warren DS, James NT, Montgomery RA, Segev DL.

Transplantation. 2012 Mar 27;93(6):603-9. doi: 10.1097/TP.0b013e318245b2af.

11.

Humoral immunity and antibody-mediated rejection in solid organ transplantation.

Montgomery RA, Cozzi E, West LJ, Warren DS.

Semin Immunol. 2011 Aug;23(4):224-34. doi: 10.1016/j.smim.2011.08.021. Epub 2011 Sep 29. Review.

PMID:
21958960
12.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

13.

Incompatible live-donor kidney transplantation in the United States: results of a national survey.

Garonzik Wang JM, Montgomery RA, Kucirka LM, Berger JC, Warren DS, Segev DL.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2041-6. doi: 10.2215/CJN.02940311. Epub 2011 Jul 22.

14.

Perturbation of thymocyte development in nonsense-mediated decay (NMD)-deficient mice.

Frischmeyer-Guerrerio PA, Montgomery RA, Warren DS, Cooke SK, Lutz J, Sonnenday CJ, Guerrerio AL, Dietz HC.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10638-43. doi: 10.1073/pnas.1019352108. Epub 2011 Jun 13.

15.

Stem cell mobilization is life saving in an animal model of acute liver failure.

Mark AL, Sun Z, Warren DS, Lonze BE, Knabel MK, Melville Williams GM, Locke JE, Montgomery RA, Cameron AM.

Ann Surg. 2010 Oct;252(4):591-6. doi: 10.1097/SLA.0b013e3181f4e479.

16.

Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange.

Warren DS, Montgomery RA.

Immunol Res. 2010 Jul;47(1-3):257-64. doi: 10.1007/s12026-009-8157-y. Review.

PMID:
20087679
17.

Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.

Locke JE, Zachary AA, Warren DS, Segev DL, Houp JA, Montgomery RA, Leffell MS.

Am J Transplant. 2009 Sep;9(9):2136-9. doi: 10.1111/j.1600-6143.2009.02764.x. Epub 2009 Jul 30.

18.

Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations.

Kraus ES, Parekh RS, Oberai P, Lepley D, Segev DL, Bagnasco S, Collins V, Leffell M, Lucas D, Rabb H, Racusen LC, Singer AL, Stewart ZA, Warren DS, Zachary AA, Haas M, Montgomery RA.

Am J Transplant. 2009 Aug;9(8):1826-34. doi: 10.1111/j.1600-6143.2009.02701.x. Epub 2009 Jun 16.

19.

ABO incompatible renal transplantation: a paradigm ready for broad implementation.

Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, Cooper M, Simpkins CE, Singer AL, Stewart ZA, Melancon JK, Ratner L, Zachary AA, Haas M.

Transplantation. 2009 Apr 27;87(8):1246-55. doi: 10.1097/TP.0b013e31819f2024.

PMID:
19384174
20.

Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants.

Stewart ZA, Lonze BE, Warren DS, Dagher NN, Singer AL, Montgomery RA, Segev DL.

Am J Transplant. 2009 May;9(5):1048-54. doi: 10.1111/j.1600-6143.2008.02545.x. Epub 2009 Mar 3.

21.

Kidney transplantation in previous heart or lung recipients.

Lonze BE, Warren DS, Stewart ZA, Dagher NN, Singer AL, Shah AS, Montgomery RA, Segev DL.

Am J Transplant. 2009 Mar;9(3):578-85. doi: 10.1111/j.1600-6143.2008.02540.x.

22.

Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss.

Locke JE, Montgomery RA, Warren DS, Subramanian A, Segev DL.

Arch Surg. 2009 Jan;144(1):83-6. doi: 10.1001/archsurg.2008.508.

PMID:
19153330
23.

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection.

Locke JE, Magro CM, Singer AL, Segev DL, Haas M, Hillel AT, King KE, Kraus E, Lees LM, Melancon JK, Stewart ZA, Warren DS, Zachary AA, Montgomery RA.

Am J Transplant. 2009 Jan;9(1):231-5. doi: 10.1111/j.1600-6143.2008.02451.x. Epub 2008 Oct 31.

24.

Generation of humanized animal livers using embryoid body-derived stem cell transplant.

Locke JE, Sun Z, Warren DS, Sheets TP, Holzer H, Shamblott MJ, Montgomery RA, Cameron AM.

Ann Surg. 2008 Sep;248(3):487-93. doi: 10.1097/SLA.0b013e318185e821.

PMID:
18791369
25.

C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA.

J Am Soc Nephrol. 2009 Jan;20(1):197-204. doi: 10.1681/ASN.2008030279. Epub 2008 Sep 5.

26.

Infrared spectroscopic and DFT vibrational mode study of perfluoro(2-ethoxyethane) sulfonic acid (PES), a model nafion side-chain molecule.

Warren DS, McQuillan AJ.

J Phys Chem B. 2008 Aug 28;112(34):10535-43. doi: 10.1021/jp801838n. Epub 2008 Aug 6.

PMID:
18681477
27.

Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.

Locke JE, Warren DS, Dominici F, Cameron AM, Leffell MS, McRann DA, Melancon JK, Segev DL, Simpkins CE, Singer AL, Zachary AA, Montgomery RA.

J Am Soc Nephrol. 2008 Oct;19(10):2011-9. doi: 10.1681/ASN.2008010078. Epub 2008 Jul 23.

28.

Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.

Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, Montgomery RA, Danovitch G, Cameron AM.

Transplantation. 2008 Apr 15;85(7):935-42. doi: 10.1097/TP.0b013e318168476d.

PMID:
18408571
29.

Rescue splenectomy for severe acute antibody-mediated rejection.

Locke JE, Zachary AA, Mohammed BS, Warren DS, Montgomery RA.

Clin Transpl. 2006:518-20. No abstract available.

PMID:
18365416
30.

Obesity impacts access to kidney transplantation.

Segev DL, Simpkins CE, Thompson RE, Locke JE, Warren DS, Montgomery RA.

J Am Soc Nephrol. 2008 Feb;19(2):349-55. Epub 2007 Dec 19.

31.

Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation.

Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA.

Am J Transplant. 2007 Jul;7(7):1797-807. Epub 2007 May 25.

32.

The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.

Locke JE, Zachary AA, Haas M, Melancon JK, Warren DS, Simpkins CE, Segev DL, Montgomery RA.

Am J Transplant. 2007 Apr;7(4):842-6.

33.

Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts.

Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES.

Am J Transplant. 2007 Mar;7(3):576-85. Epub 2007 Jan 4.

34.

Cold ischemia time and allograft outcomes in live donor renal transplantation: is live donor organ transport feasible?

Simpkins CE, Montgomery RA, Hawxby AM, Locke JE, Gentry SE, Warren DS, Segev DL.

Am J Transplant. 2007 Jan;7(1):99-107.

35.

C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings.

Haas M, Rahman MH, Racusen LC, Kraus ES, Bagnasco SM, Segev DL, Simpkins CE, Warren DS, King KE, Zachary AA, Montgomery RA.

Am J Transplant. 2006 Aug;6(8):1829-40.

36.

Domino paired kidney donation: a strategy to make best use of live non-directed donation.

Montgomery RA, Gentry SE, Marks WH, Warren DS, Hiller J, Houp J, Zachary AA, Melancon JK, Maley WR, Rabb H, Simpkins C, Segev DL.

Lancet. 2006 Jul 29;368(9533):419-21. No abstract available.

PMID:
16876670
37.

Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation.

Montgomery RA, Zachary AA, Ratner LE, Segev DL, Hiller JM, Houp J, Cooper M, Kavoussi L, Jarrett T, Burdick J, Maley WR, Melancon JK, Kozlowski T, Simpkins CE, Phillips M, Desai A, Collins V, Reeb B, Kraus E, Rabb H, Leffell MS, Warren DS.

JAMA. 2005 Oct 5;294(13):1655-63.

PMID:
16204665
38.

ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment.

Segev DL, Simpkins CE, Warren DS, King KE, Shirey RS, Maley WR, Melancon JK, Cooper M, Kozlowski T, Montgomery RA.

Am J Transplant. 2005 Oct;5(10):2570-5.

39.

Modulating alloimmune responses with plasmapheresis and IVIG.

Warren DS, Simpkins CE, Cooper M, Montgomery RA.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Jun;5(3):215-22. Review.

PMID:
15975035
40.

Kidney paired donation and optimizing the use of live donor organs.

Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA.

JAMA. 2005 Apr 20;293(15):1883-90.

PMID:
15840863
41.

A novel chimeric ribozyme vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium.

Sonnenday CJ, Warren DS, Cooke SK, Dietz HC, Montgomery RA.

J Gene Med. 2004 Dec;6(12):1394-402.

PMID:
15538724
42.

Renal transplantation at the Johns Hopkins Comprehensive Transplant Center.

Montgomery RA, Cooper M, Kraus E, Rabb H, Samaniego M, Simpkins CE, Sonnenday CJ, Ugarte RM, Warren DS, Zachary AA.

Clin Transpl. 2003:199-213. Review.

PMID:
15387112
43.

Antibody, complement and accommodation in ABO-incompatible transplants.

King KE, Warren DS, Samaniego-Picota M, Campbell-Lee S, Montgomery RA, Baldwin WM 3rd.

Curr Opin Immunol. 2004 Oct;16(5):545-9. Review.

PMID:
15341997
44.

Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy.

Sonnenday CJ, Warren DS, Cooper M, Samaniego M, Haas M, King KE, Shirey RS, Simpkins CE, Montgomery RA.

Am J Transplant. 2004 Aug;4(8):1315-22.

45.

Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers.

Warren DS, Zachary AA, Sonnenday CJ, King KE, Cooper M, Ratner LE, Shirey RS, Haas M, Leffell MS, Montgomery RA.

Am J Transplant. 2004 Apr;4(4):561-8.

46.

Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match.

Sonnenday CJ, Ratner LE, Zachary AA, Burdick JF, Samaniego MD, Kraus E, Warren DS, Montgomery RA.

Transplant Proc. 2002 Aug;34(5):1614-6. No abstract available.

PMID:
12176507
47.

Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients.

Warren DS, Wolfe BD, Gould SJ.

Hum Mutat. 2000;15(6):509-21.

PMID:
10862081
48.

PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import.

Chang CC, Warren DS, Sacksteder KA, Gould SJ.

J Cell Biol. 1999 Nov 15;147(4):761-74.

49.

Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders.

Warren DS, Morrell JC, Moser HW, Valle D, Gould SJ.

Am J Hum Genet. 1998 Aug;63(2):347-59.

50.

Time-limited action-oriented psychotherapy in a general hospital with focus on separation: follow-up of twelve patients.

McCormick ES, Warren DS, Zucker JM.

R I Med J. 1982 Oct;65(10):411-7. No abstract available.

PMID:
6959215

Supplemental Content

Loading ...
Support Center